跳至主要内容
临床试验/NCT04581642
NCT04581642已完成不适用

Nociception-Level (NOL) for the Assessment of Pain in Patient Unable to Self-Report: An Exploratory, Prospective, Unblinded, Single-center Study- The MoNOLog Study

Medasense Biometrics Ltd1 个研究点 分布在 1 个国家目标入组 33 人开始时间: 2020年11月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
33
试验地点
1
主要终点
Efficacy outcome

研究概览

简要总结

In this study we aimed to investigate the performance and effectiveness of NOL and/or NOLedge as a tool for pain assessment in geriatric and critical ill non communicating patients.

Our hypothesis was that NOL and the NOLedge may have good correlation with the health-care professional assessment PAINAD, BPS values, even with the use of the drugs affecting autonomic nervous system.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male and female, Age > 18 years old.
  • Spontaneously breathing or mechanically ventilated
  • Any patient who is unable to express his/her own level of personal pain by using visual scales according to the hospital standard
  • Written informed consent provided by the participant (if they have capacity) or guardian (if they do not have capacity) or a written proxy informed consent from a legally authorized representative empowered to make health-related decisions for the potential study participant.

排除标准

  • A patient whose staff or research team believes that his or her participation in the research will cause suffering to the patient.
  • Unstable condition preventing planned routine procedures of care, and conditions precluding the use of PMD-200: absence of sinus cardiac rhythm.

结局指标

主要结局

Efficacy outcome

时间窗: 10 months

The ability of the NOL index to discriminate between periods of painful and non-painful periods

次要结局

  • Efficacy outcome(10 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验